Echo Therapeutics Inc (NASDAQ:ECTE)

2.02
Data as of 3:59pm ET
 -0.01 / -0.49%
Today’s Change
1.53
Today|||52-Week Range
4.91
-35.67%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$24.2M

Company Description

Echo Therapeutics, Inc. is a transdermal medical device company with significant expertise in advanced skin permeation technology. The company is involved in developing Prelude SkinPrep System, which is a platform technology to allow painless skin permeation that would enable both needle-free drug delivery and analyte extraction; and Symphony CGM System, a non-invasive, wireless, and transdermal continuous glucose monitoring system for use in hospital critical care units and for patients with diabetes. It also engages in the development of specialty pharmaceuticals based on its proprietary AzoneTS transdermal drug reformulation technology. The company's drug candidate is Durhalieve, an AzoneTS formulation of triamcinolone acetonide for the treatment of corticosteroid-responsive dermatoses. Echo Therapeutics was founded on September 14, 2007 and is headquartered in Philadelphia, PA.

Contact Information

Echo Therapeutics, Inc.
8 Penn Center
Philadelphia Pennsylvania 19103
P:(215) 717-4100
Investor Relations:
(215) 717-4104

Employees

Shareholders

Other institutional22.76%
Individual stakeholders20.45%
Mutual fund holders2.23%

Top Executives

Kimberly A. BurkeCEO, Secretary, Chief Compliance Officer & SVP
Marshall D. DeweeseSenior Vice President-Operations
Charles Thomas BernhardtChief Financial Officer
Kenneth GarySenior Vice President-Research & Development
Mary McNamara-CullinaneVice President-Regulatory & Clinical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.